A Phase 1b Open-Label Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel in Subjects With Acne Vulgaris Under Maximal Use Conditions
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2017
At a glance
- Drugs IDP 120 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Ortho Dermatologics; Valeant Pharmaceuticals International
- 20 Sep 2017 Status changed from recruiting to completed.
- 27 Jul 2017 According to Valeant Pharmaceuticals International media release, Valeant Pharmaceuticals International renamed its dermatolgy unit as Ortho Dermatologics.
- 02 Aug 2016 New trial record